SOL S.p.A. Share Price

Equities

SOL

IT0001206769

Commodity Chemicals

Market Closed - Borsa Italiana 16:44:59 26/04/2024 BST 5-day change 1st Jan Change
35 EUR +1.01% Intraday chart for SOL S.p.A. +1.60% +25.90%

Financials

Sales 2024 * 1.6B 1.71B 137B Sales 2025 * 1.72B 1.83B 147B Capitalization 3.17B 3.39B 272B
Net income 2024 * 161M 172M 13.79B Net income 2025 * 174M 186M 14.9B EV / Sales 2024 * 2.26 x
Net Debt 2024 * 429M 459M 36.73B Net Debt 2025 * 424M 453M 36.3B EV / Sales 2025 * 2.1 x
P/E ratio 2024 *
19.7 x
P/E ratio 2025 *
18.2 x
Employees 6,372
Yield 2024 *
1.26%
Yield 2025 *
1.37%
Free-Float 36.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.01%
1 week+1.60%
Current month+5.58%
1 month+11.11%
3 months+32.33%
6 months+30.84%
Current year+25.90%
More quotes
1 week
33.90
Extreme 33.9
35.60
1 month
32.15
Extreme 32.15
35.80
Current year
25.60
Extreme 25.6
35.80
1 year
24.00
Extreme 24
35.80
3 years
15.12
Extreme 15.12
35.80
5 years
8.00
Extreme 8
35.80
10 years
5.51
Extreme 5.51
35.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 03/09/90
Chief Executive Officer 66 14/05/90
Director of Finance/CFO - -
Members of the board TitleAgeSince
Chief Executive Officer 62 03/09/90
Director/Board Member 65 26/04/98
Director/Board Member 62 -
More insiders
Date Price Change Volume
26/04/24 35 +1.01% 18,065
25/04/24 34.65 0.00% 27,699
24/04/24 34.65 -1.14% 38,236
23/04/24 35.05 +1.30% 11,887
22/04/24 34.6 +0.44% 24,032

Real-time Borsa Italiana, April 26, 2024 at 04:44 pm

More quotes
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
35 EUR
Average target price
38 EUR
Spread / Average Target
+8.57%
Consensus

Annual profits - Rate of surprise